Company Description
BioSig Technologies, Inc., together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias.
The company offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures.
It also focuses on enhancing intracardiac signal acquisition and diagnostic information for catheter ablation procedures for arrhythmias.
The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems.
BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
Country | United States |
Founded | 2009 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 4 |
CEO | Frederick D. Hrkac |
Contact Details
Address: 55 Greens Farms Road Westport, Connecticut 06880 United States | |
Phone | (203) 409-5444 |
Website | biosig.com |
Stock Details
Ticker Symbol | BSGM |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001530766 |
CUSIP Number | 09073N201 |
ISIN Number | US09073N3008 |
Employer ID | 26-4333375 |
SIC Code | 3845 |
Key Executives
Name | Position |
---|---|
Frederick D. Hrkac | President, Principal Executive Officer and Executive Vice President |
Dr. Budimir S. Drakulic Ph.D. | Chief Scientist |
Andrew Gornell Ballou | Vice President of Investor Relations |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 16, 2024 | 10-K | Annual Report |
Apr 2, 2024 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
Mar 18, 2024 | 8-K | Current Report |
Mar 12, 2024 | 8-K | Current Report |
Mar 11, 2024 | 144 | Filing |
Mar 11, 2024 | 8-K | Current Report |
Feb 28, 2024 | 8-K | Current Report |
Feb 21, 2024 | 8-K | Current Report |
Feb 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Feb 6, 2024 | 8-K | Current Report |